0001171843-18-002393.txt : 20180330
0001171843-18-002393.hdr.sgml : 20180330
20180330171408
ACCESSION NUMBER: 0001171843-18-002393
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180328
FILED AS OF DATE: 20180330
DATE AS OF CHANGE: 20180330
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Harrelson Lori R.
CENTRAL INDEX KEY: 0001543053
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35443
FILM NUMBER: 18726641
MAIL ADDRESS:
STREET 1: 4233 TECHNOLOGY DRIVE
CITY: DURHAM
STATE: NC
ZIP: 27704
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ARGOS THERAPEUTICS INC
CENTRAL INDEX KEY: 0001105533
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 562110007
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4233 TECHNOLOGY DR
CITY: DURHAM
STATE: NC
ZIP: 27704
BUSINESS PHONE: 9192876300
MAIL ADDRESS:
STREET 1: 4233 TECHNOLOGY DR
CITY: DURHAM
STATE: NC
ZIP: 27704
FORMER COMPANY:
FORMER CONFORMED NAME: MERIX BIOSCIENCE INC
DATE OF NAME CHANGE: 20000207
4
1
form4.xml
OWNERSHIP DOCUMENT
X0306
4
2018-03-28
0
0001105533
ARGOS THERAPEUTICS INC
ARGS
0001543053
Harrelson Lori R.
C/O ARGOS THERAPEUTICS, INC.
4233 TECHNOLOGY DRIVE
DURHAM
NC
27704
0
1
0
0
Vice President of Finance
Common Stock
2018-03-28
4
A
0
22629
0
A
34405
D
The shares are subject to a lapsing right of repurchase by the issuer, which shall lapse as to 11,315 shares on June 15, 2018, and with respect to the remaining 11,314 shares on December 14, 2018, subject to the Reporting Person continuing to be an employee of the issuer through each such date.
/s/ Lori R. Harrelson
2018-03-30